Document is current

Any future updates will be listed below

A meta-analysis of the effects of glucagon-like-peptide 1 receptor agonist (GLP1-RA) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D)

Crossref DOI link: https://doi.org/10.1038/s41598-021-01663-y

Published Online: 2021-11-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark